Sirona Biochem Renews Agreement with CURE Intelligence for Marketing and Communications Support
18 janv. 2022 03h00 HE
|
Sirona Biochem Corp.
VANCOUVER, British Columbia, Jan. 18, 2022 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (US-OTC: SRBCF) (“Sirona”) is pleased to announce that it has renewed an agreement with...
Sirona Biochem Sponsors Fluorine Chemistry Symposium, Normandy, France
12 janv. 2022 03h00 HE
|
Sirona Biochem Corp.
VANCOUVER, British Columbia, Jan. 12, 2022 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“Sirona”) is pleased to announce sponsorship of the French Fluorine...
Sirona Biochem CEO Quarterly Update
04 janv. 2022 03h00 HE
|
Sirona Biochem Corp.
VANCOUVER, British Columbia, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“Sirona”) is pleased to provide the following update to shareholders. Dear...
Sirona Biochem Engages Consultant for Japanese Market Penetration
17 oct. 2018 08h00 HE
|
Sirona Biochem Corp.
VANCOUVER, British Columbia , Oct. 17, 2018 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (Xetra: ZSB) (the “Company”) is pleased to announce that it has engaged Mr. Sven...
Sirona Biochem Announces Close of Financing and Extension of Convertible Notes
16 oct. 2018 18h00 HE
|
Sirona Biochem Corp.
VANCOUVER, British Columbia, Oct. 16, 2018 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (Frankfurt: ZSB) (the “Company”) announced that it has closed a private placement (subject to TSX.V...
Sirona Biochem to Present at the 2018 Arctic Circle Assembly
11 oct. 2018 08h00 HE
|
Sirona Biochem Corp.
VANCOUVER, British Columbia, Oct. 11, 2018 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (the “Company”) announced today that Chief Scientific Officer, Dr. Geraldine...
Sirona Biochem CEO’s Report on Progress
28 sept. 2018 08h00 HE
|
Sirona Biochem Corp.
VANCOUVER, British Columbia, Sept. 28, 2018 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (Xetra: ZSB) (the “Company”) provided a shareholder corporate update today from the...
Sirona Biochem Receives Positive Safety Data for Lead Skin-Lightener in Preparation for Clinical Trial in the US
26 sept. 2018 08h00 HE
|
Sirona Biochem Corp.
VANCOUVER, British Columbia , Sept. 26, 2018 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (Xetra: ZSB) (the “Company”) is pleased to report further progress regarding the...
Sirona Biochem Receives $500,000 USD Milestone Payment from Wanbang Biopharmaceuticals
28 août 2018 08h00 HE
|
Sirona Biochem Corp.
VANCOUVER, British Columbia, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (Xetra: ZSB) (the “Company”) announced that it has received the $500,000 USD milestone...
Sirona Biochem Announces CFDA Approval of SGLT2 Inhibitor for Phase I Clinical Trial
12 juil. 2018 08h00 HE
|
Sirona Biochem Corp.
VANCOUVER, British Columbia, July 12, 2018 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V:SBM) (FSE:ZSB) (the “Company”) announced today that partner, Jiangsu Wanbang Biopharmaceuticals...